George Peng - 30 Jun 2021 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Jul 2021, 19:54:47 UTC
Next SEC filing
07 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ George Peng

Key filing fact

George Peng filed Form 4 for Ensysce Biosciences, Inc. (ENSC) on 01 Jul 2021.

Key facts

  • This page summarizes George Peng's Form 4 filing for Ensysce Biosciences, Inc. (ENSC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 01 Jul 2021, 19:54.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$15,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENSC transaction Derivative

Warrants

Award

Transaction value
$15,000
Shares
+15,000
Change %
Price
$1.00
Shares after
15,000
Date
30 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$11.50
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

George Peng is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the "Issuer"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Peng served as the Issuer's Chief Financial Officer until the closing of the business combination.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .